Friday 6 November 2026 Export ALNY’s income statement to Excel — free account

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, up 65.2% from fiscal 2024.

Revenue: +16.7%
EPS: +747.6%
Free cash flow: −4.76%
Total debt: −2.66%

Quarter to September 2026, against a year earlier

156.93 0.27 +0.17%

Follow ALNY

Alert me

Market cap: $21.0B
P/E: 7.9×
Fwd P/E: 13.5×
Dividend yield: —
F-score: 6/9
Altman Z: 7.30
Beneish M: −1.95
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Alnylam Pharmaceuticals, Inc. (ALNY) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Alnylam Pharmaceuticals, Inc. (ALNY) trades at a P/E ratio of 7.9×. Over the past ten years it has ranged from 0.0× (September 2025) to 806× (October 2025); the current reading is higher than 91% of that period. That is below the Biotechnology industry median of 10.3× and below the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ALNY/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Alnylam Pharmaceuticals, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ALNY/metrics/pe-ratio">Alnylam Pharmaceuticals, Inc. (ALNY) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	189×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Sep 2026	12.5×	(77.12%)
Jun 2026	54.4×	(37.65%)
Mar 2026	87.3×	(53.91%)
Dec 2025	189×	(74.69%)
43 more quarters	Free account

Against its own ten years

Low 0.0× High 806×

Ten-year median 0.0×

Current reading's percentile 91

Company	P/E ratio
ROIV Roivant Sciences Ltd. compare	n/m
BNTX BioNTech SE Sponsored ADR compare	n/m
BBIO BridgeBio Pharma, Inc. compare	n/m
INSM Insmed, Inc. compare	n/m
ALNY Alnylam Pharmaceuticals, Inc.	7.9×
ASND Ascendis Pharma A/S compare	18.3×
EXEL Exelixis, Inc. compare	19.9×
INCY Incyte Corporation compare	56.3×
JAZZ Jazz Pharmaceuticals PLC compare	62.6×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Alnylam Pharmaceuticals, Inc. (ALNY) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ALNY

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ALNY

Stockrow Weekly